gabapentin sold brand name neurontin among others anticonvulsant medication primarily used treat partial seizures neuropathic commonly used medication treatment neuropathic pain caused diabetic neuropathy postherpetic neuralgia central moderately effective given gabapentin diabetic neuropathy postherpetic neuralgia meaningful sleepiness dizziness common side effects serious side effects include increased risk suicide respiratory depression allergic lower doses recommended kidney gabapentin acts decreasing activity subset calcium gabapentin first approved use available generic medication united states since tenth commonly prescribed medication united states million parkedavis subsidiary pfizer used number illegal techniques encourage physicians united states prescribe gabapentin unapproved paid millions dollars settle lawsuits regarding gabapentin recommended use focal seizures neuropathic gabapentin widely prescribed offlabel us example treatment nonneuropathic anxiety disorders bipolar concern regarding gabapentins offlabel use due lack strong scientific evidence efficacy multiple conditions proven side gabapentin approved treatment focal however effective generalized gabapentin recommended firstline treatment chronic neuropathic pain various medical general recommendation applicable neuropathic pain syndromes except trigeminal neuralgia may used second thirdline regard specific diagnoses systematic review found evidence gabapentin provide pain relief patients postherpetic neuralgia diabetic gabapentin approved former indication addition two neuropathies european federation neurological societies guideline notes gabapentin effectiveness central combination gabapentin opioid nortriptyline may work better either drug gabapentin shows substantial benefit least pain relief patient global impression change pgic much improved neuropathic pain postherpetic neuralgia peripheral diabetic neuropathy subjects treated compared treated evidence finds little benefit significant risk chronic low back pain gabapentin effective hivassociated sensory neuropathic pain due small amount research use gabapentin treatment anxiety gabapentin effective longterm treatment social anxiety disorder reducing preoperative controlled trial breast cancer survivors trial social gabapentin significantly reduced anxiety levels panic disorder gabapentin produced mixed gabapentin effective treating sleep disorders insomnia restless legs syndrome result underlying illness comes risk discontinuation withdrawal symptoms prolonged use higher gabapentin enhances slowwave sleep patients primary insomnia also improves sleep quality elevating sleep efficiency decreasing spontaneous gabapentin moderately effective reducing symptoms alcohol withdrawal associated evidence favor gabapentin weak treatment alcoholism contribute achievement abstinence data relapse heavy drinking percent days abstinent robustly favor gabapentin decreases percent days heavy gabapentin ineffective cocaine dependence methamphetamine increase rate smoking studies indicate gabapentin significantly reduce symptoms opiate withdrawal increasing evidence gabapentinoids effective controlling symptoms opiate detoxification clinical study iran heroin dependence significant social public health problem showed gabapentin produced positive results inpatient therapy program particularly reducing opioidinduced hyperalgesia drug insufficient evidence use cannabis gabapentin recommended firstline treatment acquired pendular nystagmus torsional nystagmus infantile nystagmus however work periodic alternating gabapentin decreases frequency hot flashes menopausal women patients breast cancer however antidepressants similar efficacy treatment estrogen effectively prevents hot gabapentin reduces spasticity multiple sclerosis prescribed one firstline established treatment restless legs gabapentin alleviates itching kidney failure uremic itching may option essential orthostatic although efficacy gabapentin insomnia established alleviate sleep disorder patients medical gabapentin appear provide benefit bipolar complex regional pain postsurgical prevent episodic migraine gabapentin used carefully lower doses people kidney problems due possible accumulation toxicity unclear safe pregnancy dizziness somnolence frequent side fatigue ataxia peripheral edema swelling extremities nystagmus also gabapentin associated weight gain kg lb months case studies indicate may cause anorgasmia erectile well disappear discontinuing gabapentin replacing medication dress anaphylaxis respiratory depression increased suicide behavior rare serious side effects urinary incontinence associated gabapentin rarely reported literature noteworthy side effect already verified gabapentin label contains warning increased risk suicidal thoughts according insurance claims database study gabapentin use associated increased risk suicide suicide attempt violent death compared reference anticonvulsant drug topiramate risk increased bipolar disorder epilepsy another study shown approximately doubled rate suicide attempts selfharm patients bipolar disorder taking gabapentin versus taking large swedish study suggests gabapentinoids associated increased risk suicidal behaviour unintentional overdoses headbody injuries road traffic incidents serious breathing suppression potentially fatal may occur gabapentin taken together opioids benzodiazepines depressants people underlying lung problems gabapentin opioids commonly prescribed abused together research indicates breathing suppression cause additive example gabapentin use joint replacement laparoscopic surgery increased risk respiratory depression withdrawal symptoms typically occur days abruptly stopping gabapentin almost unambiguously due extended use shortterm rebound phenomenon similar albeit less intense virtually agitation confusion disorientation frequently reported followed gastrointestinal complaints sweating rare tremor tachycardia hypertension cases users experience withdrawal seizures chronic semichronic use absence periodic cycles breaks repeating consecutive symptoms subside gabapentin tapered gradually appropriate ratecitation needed gabapentin appears substantial addictive power human animal experiments shows limited rewarding effects vast majority people abusing gabapentin current former abusers opioids persons gabapentin boost opioid high well decrease commonly experienced opioidwithdrawal symptoms excessive ingestion accidental otherwise persons may experience overdose symptoms including drowsiness sedation blurred vision slurred speech somnolence uncontrollable jerking motions anxiety high amount taken associated breathing suppression coma possibly death particularly combined alcohol gabapentin ligand calcium channel auxiliary protein connected main subunit channelforming protein high voltage activated voltagedependent calcium channels ltype ntype pq type gabapentin direct channel blocker exerts actions disrupting regulatory function interactions proteins gabapentin prevents delivery calcium channels cell membrane reduces activation channels subunit decreases signaling leading neurotransmitters release disrupts interactions nmda receptors neurexins four known isoforms protein gabapentin binds similar high affinity two pharmacological properties gabapentin explained binding one isoform endogenous αamino acids lleucine lisoleucine resemble gabapentin chemical structure bind similar affinity gabapentin present human cerebrospinal fluid micromolar may endogenous ligands subunit competitively antagonize effects accordingly gabapentin nanomolar affinity subunit potency vivo low micromolar range competition binding endogenous lamino acids likely responsible gabapentin potent activator voltagegated potassium channels even low nanomolar concentrations however activation unlikely dominant mechanism gabapentins therapeutic despite fact gabapentin structural gaba analogue spite name bind gaba receptors convert gabatooltip γaminobutyric acid another gaba receptor agonist vivo modulate gaba transport gabapentin absorbed intestines active transport process mediated via amino acid transporter presumably result pharmacokinetics gabapentin dosedependent diminished bioavailability delayed peak levels higher oral bioavailability gabapentin approximately mg administered three times daily every hours decreases mg mg mg mg mg dosing drugs increase transit time gabapentin small intestine increase oral bioavailability gabapentin coadministered oral morphine oral bioavailability mg dose gabapentin increased gabapentin low dose mg tmax time peak levels approximately hours tmax increases hours higher food significantly affect tmax gabapentin increases cmax areaundercurve levels gabapentin approximately gabapentin cross barrier enter central nervous gabapentin concentration cerebrospinal fluid approximately blood plasma due low gabapentin requires active transport across highly expressed transports gabapentin across intestinal absorption mediated amino acid transporter transport gabapentin across barrier gabapentin bind drug transporters pglycoprotein significantly bound plasma proteins gabapentin undergoes little gabapentin eliminated renally relatively short elimination halflife reported average value value changes increasing doses hours mg single dose hours mg short elimination halflife gabapentin must administered times per day maintain therapeutic gabapentin xr brand name gralise taken gabapentin derivative gaba therefore gaba analogue well γamino specifically derivative gaba pentyl disubstitution position hence name gabapentin way form sixmembered ring formation ring amine carboxylic groups relative positions conformationally process chemical synthesis isolation gabapentin high yield starts conversion anhydride acid monoamide followed hofmann rearrangement aqueous solution sodium hypobromite prepared situ gabapentin designed researchers parkedavis analogue neurotransmitter gaba could easily cross barrier first described satzinger brand name neurontin first approved may treatment epilepsy united approval us food drug administration followed december use adjuvant effective added antiseizure drugs medication control partial seizures adults indication extended children subsequently gabapentin approved united states treatment postherpetic neuralgia generic version gabapentin first became available united states extendedrelease formulation gabapentin oncedaily administration brand name gralise approved united states treatment postherpetic neuralgia january effective april united kingdom reclassified drug class c controlled effective july kentucky classified gabapentin schedule v controlled substance effective january michigan also classified gabapentin schedule v controlled gabapentin scheduled v drug states west gabapentin scheduled considered controlled substance per controlled substances act federal level although small noncontrolled studies sponsored gabapentins treatment bipolar disorder gabapentin may preponderance evidence suggests subsequent corporate acquisition original patent holder pharmaceutical company pfizer admitted violations fda guidelines regarding promotion unproven offlabel uses gabapentin franklin v parkedavis case see offlabel prescriptions common number drugs marketing offlabel uses drug warnerlambert subsequently acquired pfizer agreed plead guilty activities parkedavis subsidiary pay million fines settle civil criminal charges regarding marketing neurontin offlabel purposes settlement one largest us history first offlabel promotion case brought successfully false claims reuters reported march pfizer inc violated federal racketeering law improperly promoting epilepsy drug neurontin federal rico law penalty automatically tripled finding cost pfizer case stems claim kaiser foundation health plan inc misled believing neurontin effective offlabel treatment migraines bipolar disorder conditions pfizer argued kaiser physicians still recommend drug insurers website also still lists neurontin drug neuropathic wall street journal noted pfizer spokesman christopher loder said disappointed verdict pursue posttrial motions later added verdict judges rulings consistent facts gabasync treatment consisting combination gabapentin two medications flumazenil hydroxyzine well therapy ineffective treatment promoted methamphetamine addiction though also claimed effective dependence alcohol marketed prometa individual drugs approved fda offlabel use addiction treatment gabasync marketed hythiam inc owned terren peizer former junk bond salesman since indicted securities fraud relative another hythiam charges per patient license use half goes prescribing physician half november results doubleblind placebocontrolled study financed hythiam carried ucla published peerreviewed journal addiction concluded gabasync ineffective prometa protocol consisting flumazenil gabapentin hydroxyzine appears effective placebo reducing methamphetamine use retaining patients treatment reducing methamphetamine barrons november article entitled curb cravings stock wrote venture works patients investing public itll rare success peizer whos promoted series disappointing smallcap medical technology stocks since days journalist scott pelley said peizer depending talk youre either revolutionary snake oil minutes nbc news dallas morning news criticized peizer company bypassed clinical studies government approval bringing market prometa addiction drug proved completely journalist adam feuerstein opined peizer says dubioussounding gabapentin originally marketed brand name neurontin since became generic marketed worldwide using different brand extendedrelease formulation gabapentin oncedaily administration introduced postherpetic neuralgia brand name parkedavis developed drug called pregabalin related structure gabapentin successor another similar drug atagabalin unsuccessfully tried pfizer treatment prodrug form gabapentin approved us food drug administration fda gabapentin taken excess induce euphoria sense calm marijuanalike high improved sociability reduced alcohol cocaine also known streets gabapentin increasingly abused misused euphoric percent responders internet poll percent attending addiction facilities history abuse gabapentin misuse toxicity use suicide attempts among adults us increased kentuckys implementation stricter legislation regarding opioid prescriptions increase gabapentinonly multidrug use majority cases overdose suspected suicide attempts rates also accompanied increases abuse recreational withdrawal symptoms often resembling benzodiazepine withdrawal play role physical dependence users misuse predominantly coincides usage cns depressant drugs namely opioids benzodiazepines cats gabapentin used analgesic multimodal pain anxiety medication reduce stress cats travel vet veterinarians may prescribe gabapentin anticonvulsant pain reliever dogs also used treat chronic painassociated nerve inflammation horses dogs side effects include tiredness loss coordination generally go away within httpsenwikipediaorgwikigabapentin